Results of disseminating an online screen for eating disorders across the U.S.: Reach, respondent characteristics, and unmet treatment need.


Journal

The International journal of eating disorders
ISSN: 1098-108X
Titre abrégé: Int J Eat Disord
Pays: United States
ID NLM: 8111226

Informations de publication

Date de publication:
06 2019
Historique:
received: 26 10 2018
revised: 27 01 2019
accepted: 28 01 2019
pubmed: 15 2 2019
medline: 15 11 2019
entrez: 15 2 2019
Statut: ppublish

Résumé

The treatment gap between those who need and those who receive care for eating disorders is wide. Scaling a validated, online screener that makes individuals aware of the significance of their symptoms/behaviors is a crucial first step for increasing access to care. The objective of the current study was to determine the reach of disseminating an online eating disorder screener in partnership with the National Eating Disorders Association (NEDA), as well to examine the probable eating disorder diagnostic and risk breakdown of adult respondents. We also assessed receipt of any treatment. Participants completed a validated eating disorder screen on the NEDA website over 6 months in 2017. Of 71,362 respondents, 91.0% were female, 57.7% 18-24 years, 89.6% non-Hispanic, and 84.7% White. Most (86.3%) screened positive for an eating disorder. In addition, 10.2% screened as high risk for the development of an eating disorder, and only 3.4% as not at risk. Of those screening positive for an eating disorder, 85.9% had never received treatment and only 3.0% were currently in treatment. The NEDA online screen may represent an important eating disorder detection tool, as it was completed by >71,000 adult respondents over just 6 months, the majority of whom screened positive for a clinical/subclinical eating disorder. The extremely high percentage of individuals screening positive for an eating disorder who reported not being in treatment suggests a wide treatment gap and the need to offer accessible, affordable, evidence-based intervention options, directly linked with screening.

Identifiants

pubmed: 30761560
doi: 10.1002/eat.23043
pmc: PMC6555644
mid: NIHMS1017457
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

721-729

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007456
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK116925
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL130357
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092950
Pays : United States
Organisme : NICHD NIH HHS
ID : F32 HD089586
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH100455
Pays : United States

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

JAMA Intern Med. 2017 Oct 1;177(10):1527-1529
pubmed: 28759671
Int J Eat Disord. 2006 Mar;39(2):154-61
pubmed: 16252278
Clin Pract Epidemiol Ment Health. 2011;7:74-83
pubmed: 21687562
Int J Eat Disord. 2018 Nov;51(11):1285-1289
pubmed: 30488569
Int J Eat Disord. 2019 Oct;52(10):1137-1149
pubmed: 31298791
Int J Eat Disord. 2019 Oct;52(10):1125-1136
pubmed: 31268183
Int J Eat Disord. 1994 Nov;16(3):227-38
pubmed: 7833956
J Am Coll Health. 2019 May-Jun;67(4):357-366
pubmed: 29979922
Nutrients. 2017 Nov 21;9(11):
pubmed: 29160843
Psychol Assess. 2000 Jun;12(2):123-31
pubmed: 10887758
Int J Eat Disord. 2003 Mar;33(2):205-12
pubmed: 12616587
Int J Eat Disord. 2017 Mar;50(3):250-258
pubmed: 28152203
Int J Eat Disord. 2007 Apr;40(3):257-62
pubmed: 17167756
Eat Disord. 2016;24(1):20-8
pubmed: 26643133
Int J Eat Disord. 2017 Mar;50(3):170-189
pubmed: 28102908
Int J Eat Disord. 2016 Mar;49(3):238-48
pubmed: 26710932
Int J Eat Disord. 1994 Dec;16(4):363-70
pubmed: 7866415
Contemp Clin Trials. 2009 Jul;30(4):326-33
pubmed: 19275947
Eur Eat Disord Rev. 2017 Nov;25(6):432-450
pubmed: 28967161
Int J Eat Disord. 2016 Mar;49(3):249-59
pubmed: 26876429
Int J Eat Disord. 2016 Mar;49(3):216-37
pubmed: 26407541
BMJ Open. 2014 Apr 08;4(4):e004342
pubmed: 24713213
Int J Eat Disord. 2009 Mar;42(2):97-103
pubmed: 18951455
BMC Public Health. 2014 Sep 11;14:943
pubmed: 25213544
Int J Eat Disord. 2016 Mar;49(3):319-23
pubmed: 26311499
Arch Gen Psychiatry. 2011 Jul;68(7):724-31
pubmed: 21727255
Psychol Serv. 2019 May;16(2):239-249
pubmed: 30407047
J Ment Health. 2014 Apr;23(2):51-4
pubmed: 24689662
Int J Eat Disord. 2006 Dec;39(8):747-53
pubmed: 16941624
Eat Disord. 2013;21(4):310-27
pubmed: 23767672
J Am Coll Health. 2011;59(8):700-7
pubmed: 21950250
Eur Eat Disord Rev. 2017 May;25(3):165-171
pubmed: 28127825
Mhealth. 2018 Jul 10;4:25
pubmed: 30598986
Biol Psychiatry. 2007 Feb 1;61(3):348-58
pubmed: 16815322
Int J Eat Disord. 2011 Jul;44(5):412-20
pubmed: 20665700
Curr Psychiatry Rep. 2012 Aug;14(4):406-14
pubmed: 22644309
Behav Res Ther. 2017 Jan;88:49-64
pubmed: 28110676
Curr Opin Psychiatry. 2016 Nov;29(6):336-9
pubmed: 27608181

Auteurs

Ellen E Fitzsimmons-Craft (EE)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.

Katherine N Balantekin (KN)

Department of Exercise and Nutrition Sciences, University at Buffalo, Buffalo, New York.

Andrea K Graham (AK)

Department of Medical Social Sciences, Northwestern University, Chicago, Illinois.

Lauren Smolar (L)

National Eating Disorders Association, New York, New York.

Dan Park (D)

National Eating Disorders Association, New York, New York.

Claire Mysko (C)

National Eating Disorders Association, New York, New York.

Burkhardt Funk (B)

Institute of Information Systems, Leuphana University, Lüneburg, Germany.

C Barr Taylor (CB)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Center for m2Health, Palo Alto University, Palo Alto, California.

Denise E Wilfley (DE)

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH